Detected ·
T-Therapeutics Ltd
$133MSeries B
Cambridge-based T-Therapeutics raised an oversubscribed $133M Series B co-led by Advent Life Sciences and British Business Bank, with participation from JJDC, Samsara BioCapital, M Ventures, Eli Lilly, and existing investors, to advance its TCR-T cell engager therapeutics into clinical trials.
- Website
- —
- linkedin.com/company/93112302
- Amount
- $133 000 000 USD
- Stage
- Series B
- Event
- Funding round
- Detected
- 2026-11-06 00:02:47 UTC
- Signal ID
- a5bb5e6d-cd56-44cd-9b5d-ae5061ad8def
As the API returns it
{
"id": "a5bb5e6d-cd56-44cd-9b5d-ae5061ad8def",
"created_at": "2026-11-06T00:02:47.128412Z",
"company_name": "T-Therapeutics Ltd",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/93112302",
"event_type": "funding",
"funding_amount": 133000000,
"funding_currency": "USD",
"funding_stage": "series_b",
"message": "*Cambridge-based T-Therapeutics raised an oversubscribed $133M Series B co-led by Advent Life Sciences and British Business Bank, with participation from JJDC, Samsara BioCapital, M Ventures, Eli Lilly, and existing investors, to advance its TCR-T cell engager therapeutics into clinical trials.*"
}